The number of people with susceptibility test result for rifampicin in Montenegro
Montenegro: The number of people with susceptibility test result for rifampicin was 55 in 2021. ▼ Falling
Latest (2021)
55
Change on year
up 89.7%
World rank
121st
of 155 countries
All-time high
62
in 2019
All-time low
29
in 2020
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Montenegro, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
Montenegro recorded 55 for the number of people with susceptibility test result for rifampicin in 2021.
The figure is up 89.7% on the previous year and up 12.2% over five years.
That places Montenegro 121st out of 155 countries with data for 2021, putting it in the bottom quarter.
The number of people with susceptibility test result for rifampicin in Montenegro, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 49 | — |
| 2018 | 60 | +22.4% |
| 2019 | 62 | +3.3% |
| 2020 | 29 | -53.2% |
| 2021 | 55 | +89.7% |
Montenegro compared with similar countries
- Montenegro's 55 is below the median for upper middle income countries, which is 880, 6% of the median. (46 countries reporting)
- Montenegro's 55 is below the median for Europe & Central Asia, which is 229.5, 24% of the median. (44 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 57 | 49 | 62 | 3 |
| 2020s | 42 | 29 | 55 | 2 |
Countries ranked near Montenegro
More health data for Montenegro
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.1184 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,522 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.07 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0271 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.97 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Montenegro?
- The number of people with susceptibility test result for rifampicin in Montenegro was 55 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Montenegro?
- The highest recorded value was 62 in 2019.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Montenegro?
- The lowest recorded value was 29 in 2020.
- How does Montenegro rank for the number of people with susceptibility test result for rifampicin?
- Montenegro ranks 121st out of 155 countries with data for 2021.
- Where does this Montenegro data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).